Cargando…
Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19
The coronavirus disease 2019 (COVID-19) pandemic is a global public health crisis. However, little is known about the pathogenesis and biomarkers of COVID-19. Here, we profiled host responses to COVID-19 by performing plasma proteomics of a cohort of COVID-19 patients, including non-survivors and su...
Autores principales: | Shu, Ting, Ning, Wanshan, Wu, Di, Xu, Jiqian, Han, Qiangqiang, Huang, Muhan, Zou, Xiaojing, Yang, Qingyu, Yuan, Yang, Bie, Yuanyuan, Pan, Shangwen, Mu, Jingfang, Han, Yang, Yang, Xiaobo, Zhou, Hong, Li, Ruiting, Ren, Yujie, Chen, Xi, Yao, Shanglong, Qiu, Yang, Zhang, Ding-Yu, Xue, Yu, Shang, You, Zhou, Xi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574896/ https://www.ncbi.nlm.nih.gov/pubmed/33128875 http://dx.doi.org/10.1016/j.immuni.2020.10.008 |
Ejemplares similares
-
Post-mortem tissue proteomics reveals the pathogenesis of multi-organ injuries of COVID-19
por: Qiu, Yang, et al.
Publicado: (2021) -
Imaging Mass Cytometric Analysis of Postmortem Tissues Reveals Dysregulated Immune Cell and Cytokine Responses in Multiple Organs of COVID-19 Patients
por: Wang, Chong, et al.
Publicado: (2020) -
Plasma metabolomic and lipidomic alterations associated with COVID-19
por: Wu, Di, et al.
Publicado: (2020) -
SARS-Coronavirus-2 Nsp13 Possesses NTPase and RNA Helicase Activities That Can Be Inhibited by Bismuth Salts
por: Shu, Ting, et al.
Publicado: (2020) -
Remimazolam besylate for sedation of postoperative patients in intensive care units: a phase I, open label, dose-finding study
por: Tang, Yun, et al.
Publicado: (2022)